GL
Gene Logic Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Steel Partners, Ltd., was filed 29 Oct 2010.
Gene Logic Inc: what insiders have been doing
Gene Logic Inc is a listed company. Its insiders report their share dealings to SEC (Form 4). Nothing new has been filed by managers of Gene Logic Inc in twelve months, the latest record being from 29 October 2010.
Our records for Gene Logic Inc go back to 2006, with 60 purchases and 1 sale on the open market in total.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
72
Thresholds
n/a
Buy Volume
€1M
60 ops. · all time
Sell Volume
€624,550
1 ops. · all time
Financial data
· cache
Last declaration on 29 October 2010
Declarations72 total
- 125,000 shares@ US$0.255Common Stock, $.01 Par ValueSEC:0000921895-10-001596:0Canonical exit: 25 Jan 2011 (T+90)
- 68,000 shares@ US$0.255Common Stock, $.01 Par ValueSEC:0000921895-10-001596:1Canonical exit: 26 Jan 2011 (T+90)
- 2,000 shares@ US$0.62Common StockSEC:0001209191-09-054996:0Canonical exit: 28 Feb 2010 (T+90)
- 2,000 shares@ US$0.55Common StockSEC:0001209191-09-054746:0Canonical exit: 25 Feb 2010 (T+90)
- 2,000 shares@ US$0.575Common StockSEC:0001209191-09-054356:0Canonical exit: 21 Feb 2010 (T+90)
- 2,000 shares@ US$0.575Common StockSEC:0001209191-09-054356:1Canonical exit: 23 Feb 2010 (T+90)
- 2,000 shares@ US$0.64Common StockSEC:0001209191-09-053954:0Canonical exit: 18 Feb 2010 (T+90)
- 2,000 shares@ US$0.62Common StockSEC:0001209191-09-053957:0Canonical exit: 15 Feb 2010 (T+90)
- 1,980 shares@ US$0.64Common StockSEC:0001209191-09-053957:1Canonical exit: 16 Feb 2010 (T+90)
- 20 shares@ US$0.62Common StockSEC:0001209191-09-053957:2Canonical exit: 16 Feb 2010 (T+90)
- 300 shares@ US$0.6327Common StockSEC:0001209191-09-053727:0Canonical exit: 16 Feb 2010 (T+90)
- 1,700 shares@ US$0.6336Common StockSEC:0001209191-09-053727:1Canonical exit: 16 Feb 2010 (T+90)
- 2,000 shares@ US$0.58Common StockSEC:0001209191-09-042437:0Canonical exit: 25 Nov 2009 (T+90)
- 2,000 shares@ US$0.595Common StockSEC:0001209191-09-041232:0Canonical exit: 16 Nov 2009 (T+90)
- 50,000 shares@ US$1.37Common StockSEC:0001209191-08-019939:0
- 1,375,765 shares@ US$0.709Common StockSEC:0001209191-08-019020:0
- 2,267,415 shares@ US$0.709Common StockSEC:0001209191-08-019020:2
- 2,334,712 shares@ US$0.709Common StockSEC:0001209191-08-019020:3
- 25,000 shares0Common Stock GrantSEC:0001209191-07-070540:0
- 15,484 shares0Common StockSEC:0001209191-07-070538:0
- 12,300 shares@ US$0.94Common StockSEC:0001209191-07-066920:0Canonical exit: 28 Feb 2008 (T+90)
- 2,700 shares@ US$0.9499Common StockSEC:0001209191-07-066920:1Canonical exit: 28 Feb 2008 (T+90)
- 1,300 shares@ US$0.949Common StockSEC:0001209191-07-066920:2Canonical exit: 28 Feb 2008 (T+90)
- 6,700 shares@ US$0.9399Common StockSEC:0001209191-07-066920:3Canonical exit: 28 Feb 2008 (T+90)
- 800 shares@ US$0.948Common StockSEC:0001209191-07-066920:4Canonical exit: 28 Feb 2008 (T+90)
25 of 72 declarations
About Gene Logic Inc
Gene Logic Inc is a company listed on the XNAS market, specializing in biotechnology solutions. It focuses on analyzing genetic data to enhance drug research and development.
